Lung Disease Study Uses Multi-Modal Technology to Reach Participants

Increase in Study Efficacy Highlights Automated Telephone Software from Inventive Labs

Inventive Labs Corporation, a provider of telephony software and application services, and the COPDGene® Study, one of the largest studies ever to investigate the underlying genetic factors of Chronic Obstructive Pulmonary Disease or COPD, announced today the successful implementation of a web and telephone-based longitudinal follow-up solution.

The solution, powered by Inventive Labs’ Voice Elements software, automates the initial and quarterly follow-up calls to participants, enabling them to respond to study questions by either Touch Tone (pressing digits) or their voice, using speech recognition. Not only does the system gather data for willing participants, but also informs the COPDGene® Study if a participant is unreachable or unwilling to continue participation.

Before the system was installed, Study coordinators had to manage calling the participants, often multiple times, which “ate up” regional Study resources. Inventive Labs’ solution integrates a web survey, in addition to the telephone survey, and streamlines data gathering and follow-up management.

“Using Inventive Labs’ solution helps the COPDGene Study stay focused on advancing the treatment options and cure strategies for COPD,” commented James D. Crapo M.D, Professor of Medicine, National Jewish Health, and University of Colorado Denver and co-founder of the COPDGene® Study. “The customized software and service encompasses various forms of communication and technology that increase our chances for Study participation.”

“We were pleased to apply our broad services offerings to the successful deployment of the COPDGene® Study project,” said Ron Tanner, president of Inventive Labs. “Bringing telephony, IVR, speech recognition and web technology together highlights how well-constructed automation can provide enormous benefits to organizations such as COPDGene®.”